Literature DB >> 28501087

The Role of Radiotherapy in Localized Esophageal and Gastric Cancer.

John Ng1, Percy Lee2.   

Abstract

Multimodality management has become a core treatment principle for locally advanced esophageal, gastroesophageal junction (GEJ), and gastric cancer. Radiotherapy serves an important role for optimizing patient outcomes. This article reviews the evolving role of radiotherapy in the multidisciplinary management of esophageal, GEJ, and gastric cancer, summarizing the results of recent clinical trials leading to contemporary accepted treatment approaches. A major theme is the evidence supporting the role of radiotherapy in combined modality management, particularly the trend toward its delivery in the neoadjuvant setting. Also reviewed are novel radiotherapy paradigms and newer radiation technologies such as image-guided radiotherapy and MRI-guided radiotherapy.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adjuvant therapy; Esophageal cancer; Gastric cancer; Gastrointestinal radiotherapy; MRI radiation therapy; Preoperative chemoradiotherapy; Proton therapy

Mesh:

Year:  2017        PMID: 28501087     DOI: 10.1016/j.hoc.2017.01.005

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  8 in total

1.  Long-term outcomes of laparoscopy-assisted distal gastrectomy versus open distal gastrectomy for gastric cancer: a 10-year single-institution experience.

Authors:  Hao Wang; Tingyu Mou; Hao Chen; Yanfeng Hu; Tian Lin; Tuanjie Li; Jiang Yu; Hao Liu; Guoxin Li
Journal:  Surg Endosc       Date:  2018-06-25       Impact factor: 4.584

2.  TM4SF1 inhibits apoptosis and promotes proliferation, migration and invasion in human gastric cancer cells.

Authors:  Yunhai Wei; Xiaoying Shen; Liqin Li; Guoliang Cao; Xuhua Cai; Yan Wang; Hua Shen
Journal:  Oncol Lett       Date:  2018-09-06       Impact factor: 2.967

3.  Integrating radiosensitive genes improves prediction of radiosensitivity or radioresistance in patients with oesophageal cancer.

Authors:  Qiuning Zhang; Zhitong Bing; Jinhui Tian; Xiaohu Wang; Ruifeng Liu; Yi Li; Yarong Kong; Yan Yang
Journal:  Oncol Lett       Date:  2019-04-10       Impact factor: 2.967

4.  Effects of radioactive 125I on apoptosis of HGC-27 gastric cancer cells.

Authors:  Yong Yang; Aifei Chen; Jun Ma; Aiping Wu; Fazhen Xu
Journal:  Oncol Lett       Date:  2019-09-09       Impact factor: 2.967

5.  CircATIC inhibits esophageal carcinoma progression and promotes radiosensitivity by elevating RHCG through sponging miR-10-3p.

Authors:  Kai Zhang; Ruitai Fan; Deyao Zhao; Peipei Liu; Zheng Yang; Junqi Liu; Song Zhang; Shilei Rao; Yang Wang; Lixin Wan
Journal:  Thorac Cancer       Date:  2022-03-20       Impact factor: 3.500

Review 6.  Reactive Oxygen Species-Mediated Tumor Microenvironment Transformation: The Mechanism of Radioresistant Gastric Cancer.

Authors:  Huifeng Gu; Tianhe Huang; Yicheng Shen; Yin Liu; Fuling Zhou; Yanxia Jin; Haseeb Sattar; Yongchang Wei
Journal:  Oxid Med Cell Longev       Date:  2018-03-27       Impact factor: 6.543

7.  Hypoxia-Induced Upregulation of HE4 Is Responsible for Resistance to Radiation Therapy of Gastric Cancer.

Authors:  Chunwei Peng; Guangjie Liu; Kai Huang; Qiang Zheng; Yunsong Li; Changjun Yu
Journal:  Mol Ther Oncolytics       Date:  2018-12-06       Impact factor: 7.200

8.  Long-term clinical outcomes of lipiodol marking using standard gastroscopy for image-guided radiotherapy of upper gastrointestinal cancers.

Authors:  Kim Hay Be; Richard Khor; Daryl Lim Joon; Ben Starvaggi; Michael Chao; Sweet Ping Ng; Michael Ng; Leonardo Zorron Cheng Tao Pu; Marios Efthymiou; Rhys Vaughan; Sujievvan Chandran
Journal:  World J Gastroenterol       Date:  2021-11-14       Impact factor: 5.742

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.